Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 6/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | SCN1A | P35498 | 2/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.47 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5693759 | 0.89 | CYP3A4 (0.60) | CYP3A4ALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL5196832 | 0.88 | CYP3A4 (0.59) | CYP3A4ALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL9292169 | 0.84 | CYP3A4 (0.58) | CYP3A4ALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL851234 | 0.83 | CYP3A4 (0.74) | CYP3A4ALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL15485816 | 0.83 | CYP3A4 (0.74) | CYP3A4ALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL7878156 | 0.83 | CYP3A4 (0.74) | CYP3A4ALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL9421944 | 0.83 | CYP3A4 (0.74) | CYP3A4ALDH1A1TSHRHSD17B10MEN1 | |
| Bicarbonate SCHEMBL20838538 | 0.82 | CYP3A4 (0.92) | CYP3A4ALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL10764240 | 0.82 | CYP3A4 (0.46) | CYP3A4ALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL16371573 | 0.82 | CYP3A4 (1.00) | CYP3A4ALDH1A1TSHRHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2850050-B1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | GIVAUDAN SA (CH) | 2018-12-12 | — | — | EP | disclosed |
| US-9193651-B2 | Process for the chemoselective reduction of terminally saturated carboxylic esters | GIVAUDAN S.A. (CH) | 2015-11-24 | — | — | US | disclosed |
| US-20150152029-A1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | GIVAUDAN SA (CH) | 2015-06-04 | — | — | US | disclosed |
| EP-2850050-A1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | Givaudan SA (CH) | 2015-03-25 | — | — | EP | disclosed |
| EP-1846492-B1 | IMPROVEMENTS IN OR RELATING TO PLASTICISER COMPOSITIONS | EXXONMOBIL CHEM PATENTS INC (US) | 2014-10-01 | — | — | EP | disclosed |
| WO-2013171302-A1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | GIVAUDAN SA (CH) | 2013-11-21 | — | — | WO | disclosed |
| US-20100048778-A1 | Plasticiser Compositions | EXXONMOBIL CHEMICAL PATENTS INC. | 2010-02-25 | — | — | US | disclosed |
| US-7629413-B2 | flooring; C9 to C11 alkyl benzoates are used as plasticisers for polyvinyl chloride in particular in combination with plasticisers such as di-2-ethyl hexyl phthalate, diisononyl phthalate, di-2-propyl heptyl phthalate, diisodecyl phthalate or di-2-ethyl hexyl terephthalate | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-12-08 | — | — | US | disclosed |
| US-20080234414-A1 | flooring; C9 to C11 alkyl benzoates are used as plasticisers for polyvinyl chloride in particular in combination with plasticisers such as di-2-ethyl hexyl phthalate, diisononyl phthalate, di-2-propyl heptyl phthalate, diisodecyl phthalate or di-2-ethyl hexyl terephthalate | EXXONMOBIL CHEMICAL COMPANY | 2008-09-25 | — | — | US | disclosed |
| EP-1846492-A1 | IMPROVEMENTS IN OR RELATING TO PLASTICISER COMPOSITIONS | ExxonMobil Chemical Patents Inc. (US) | 2007-10-24 | — | — | EP | disclosed |
| WO-2006077131-A1 | IMPROVEMENTS IN OR RELATING TO PLASTICISER COMPOSITIONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152029-A1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | ADH5, ADH1A, ADH1C | CYP3A4 51/4885ALDH1A1 207/4885TSHR 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.